President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

The global safety needles market is poised for substantial growth, with the market’s value forecasted to rise from US$ 5,840.7 million in 2023 to an impressive US$ 11,972.7 million by 2033. This ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Diastolic ... glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; ...

Shares of drugmaker Novo Nordisk (NVO) sold off sharply last week, falling as much as 29% intraday Friday (before closing down 17%) and wiping out nearly $100B of market value in the process when ...

(CNN) — Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more ...

COPENHAGEN, Dec 20 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Friday it will begin a new trial of its experimental next-generation CagriSema drug in the first half of 2025 that it ...

Novo Nordisk falls most on record after new weight drug disappoints Novo’s shares plunged as much as 27 per cent, and they’re now down 17 per cent for the year after a previous runup on the strength ...

SEATTLE — Preparations are well underway for the largest structurally-launched firework show in North America: Alaska Airlines New Year's at the Needle celebration. Organizers are excited to put ...

This story was updated to add new information. The parent company of Danish drug maker Novo Nordisk said it completed its $16.5 billion purchase of Catalent, including the Bloomington operations ...

With Novo Nordisk’s name already synonymous with ... M.D., told Fierce Pharma the results could “really move the needle” and set a new standard for “holistic” care for many patients ...